BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 25787231)

  • 1. Metabolic adaptations in diabetic endothelial cells.
    de Zeeuw P; Wong BW; Carmeliet P
    Circ J; 2015; 79(5):934-41. PubMed ID: 25787231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanisms of endothelial dysfunction in diabetes.
    Roberts AC; Porter KE
    Diab Vasc Dis Res; 2013 Nov; 10(6):472-82. PubMed ID: 24002671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenic protein-4-induced oxidant signaling via protein carbonylation for endothelial dysfunction.
    Wong CM; Zhang Y; Huang Y
    Free Radic Biol Med; 2014 Oct; 75():178-90. PubMed ID: 25091895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus.
    King GL; Shiba T; Oliver J; Inoguchi T; Bursell SE
    Annu Rev Med; 1994; 45():179-88. PubMed ID: 8198375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination Therapy of Nifedipine and Sulphonylureas Exhibits a Mutual Antagonistic Effect on the Endothelial Cell Dysfunction Induced by Hyperglycemia Linked to Vascular Disease.
    Wang LP; Jiang Y; Yang H; Peng C; Zhang C; Tao X; Xie HH
    Cell Physiol Biochem; 2016; 38(6):2337-47. PubMed ID: 27198152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach.
    Folli F; Corradi D; Fanti P; Davalli A; Paez A; Giaccari A; Perego C; Muscogiuri G
    Curr Diabetes Rev; 2011 Sep; 7(5):313-24. PubMed ID: 21838680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of oxidative stress in diabetic angiopathy: role of mitochondrial and cellular pathways.
    Mokini Z; Marcovecchio ML; Chiarelli F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):313-21. PubMed ID: 20022399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organelle dynamics of endothelial mitochondria in diabetic angiopathy.
    Xiang H; Song R; Ouyang J; Zhu R; Shu Z; Liu Y; Wang X; Zhang D; Zhao J; Lu H
    Eur J Pharmacol; 2021 Mar; 895():173865. PubMed ID: 33460616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial cell metabolism in normal and diseased vasculature.
    Eelen G; de Zeeuw P; Simons M; Carmeliet P
    Circ Res; 2015 Mar; 116(7):1231-44. PubMed ID: 25814684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of endothelial dysfunction in the development of vascular complications of diabetes].
    Turenkov IN; Voronkov AV; Slietsans AA
    Patol Fiziol Eksp Ter; 2013; (2):80-4. PubMed ID: 24000720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A lethal tetrad in diabetes: hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction.
    Yu Y; Lyons TJ
    Am J Med Sci; 2005 Nov; 330(5):227-32. PubMed ID: 16284482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The molecular basis of diabetic microangiopathy.
    Mokini Z; Chiarelli F
    Pediatr Endocrinol Rev; 2006 Dec-2007 Jan; 4(2):138-52. PubMed ID: 17342030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High glucose induces dysfunction and apoptosis in endothelial cells: is the effect of high glucose persistence more important than concentration?
    Zhang Y; Shi H; Sun G; Li S; Xu X; Ye C; Li X; Wang S
    Exp Clin Endocrinol Diabetes; 2011 Apr; 119(4):225-33. PubMed ID: 20625972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of glycolysis-dependent DNA repair regulated by FOXO1 knockdown via PFKFB3 attenuates hyperglycemia-induced endothelial oxidative stress injury.
    Sun D; Chen S; Li S; Wang N; Zhang S; Xu L; Zhu S; Li H; Gu Q; Xu X; Wei F
    Redox Biol; 2023 Feb; 59():102589. PubMed ID: 36577299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperglycemia-Suppressed SMARCA5 Disrupts Transcriptional Homeostasis to Facilitate Endothelial Dysfunction in Diabetes.
    Wang J; Zhou H; Shao J; Zhang S; Jin J
    Diabetes Metab J; 2023 May; 47(3):366-381. PubMed ID: 36872061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells.
    Ortmann J; Nett PC; Celeiro J; Traupe T; Tornillo L; Hofmann-Lehmann R; Haas E; Frank B; Terraciano LM; Barton M
    Biochem Biophys Res Commun; 2005 Aug; 334(2):689-95. PubMed ID: 16009335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune-mediated oxidative stress and endothelial dysfunction: implications of accelerated vascular injury in type I diabetes.
    Zimmerman MA; Flores SC
    J Surg Res; 2009 Jul; 155(1):173-8. PubMed ID: 18805553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KB-R7943 inhibits high glucose-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion.
    Li J; Jin HB; Sun YM; Su Y; Wang LF
    Biochem Biophys Res Commun; 2010 Feb; 392(4):516-9. PubMed ID: 20096662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-34a and vascular senescence in diabetes.
    Thounaojam MC; Bartoli M
    Aging (Albany NY); 2019 Dec; 11(24):11799-11800. PubMed ID: 31866581
    [No Abstract]   [Full Text] [Related]  

  • 20. Boldine protects endothelial function in hyperglycemia-induced oxidative stress through an antioxidant mechanism.
    Lau YS; Tian XY; Huang Y; Murugan D; Achike FI; Mustafa MR
    Biochem Pharmacol; 2013 Feb; 85(3):367-75. PubMed ID: 23178655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.